Our Transactions

We are relentless in our commitment to achieving extraordinary outcomes that redefine the standard of excellence.

Sectors
Transaction Type

$25,000,000 Senior Debt Financing

$10,000,000 Revolving Credit Facility $15,000,000 Senior Term Loan provided by

TechHealth Completes Financing

TM Capital assisted TechHealth in arranging $25 million of senior debt financing in connection with a dividend recapitalization

Details

owner of leading OTC brands including:

has amended its senior credit facility with

C.B. Fleet Amends Senior Credit Facility

TM Capital advised C.B. Fleet in completing an amended senior credit facility

Details

has been acquired by

Chestnut Medical Acquired by ev3

TM Capital advised Chestnut Medical Technologies in its sale to ev3 Inc. (NASDAQ: EVVV) for $150 million in cash and stock

Details

has been acquired by

CryoCath Technologies Acquired by Medtronic

TM Capital advised CryoCath Technologies (TSX: CYT) in its sale to Medtronic, Inc. (NYSE: MDT) for a C$425mm enterprise value in an all-cash takeover bid

Details

has acquired

Immucor Acquires BioArray Solutions

TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.

Details

has completed a recapitalization with

MedTech Completes Recapitalization

TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity

Details

has completed a leveraged recapitalization led by

Freedom Innovations Completes Leveraged Recap

TM Capital advised Freedom Innovations and ACT Medical in a leveraged recapitalization led by Telegraph Hill Partners and Tailwind Capital Group whereby they acquired a 73% stake in the combined company

Details

has been acquired by

Dinex Acquired by Carlisle Companies

TM Capital advised Dinex Holdings, a provider of specialty foodservice products to healthcare markets, in its $95 million sale to Carlisle Companies (NYSE), a $2 billion diversified global manufacturer

Details

has been acquired by

Everest Biomedical Acquired by Stryker Corporation

TM Capital advised Everest Biomedical Instruments Co Inc. in its sale to Stryker Corporation (NYSE:SYK), a world leader in the development, manufacture and marketing of orthopedic products and medical specialties

Details

has been acquired by

BioLok Acquired by Healthpoint Capital

TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital

Details

merged with

SHPl Acquires The Med-Design Corporation

TM Capital advised Specialized Health Products International, Inc. (OTC: SHPI) in its acquisition of The Med-Design Corporation (NASDAQ: MEDC)

Details

has entered into a joint venture distribution agreement with

Immucor Forms Joint Venture with Kainos

TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.

Details

has been acquired by

NanoGram Devices Acquired by Greatbatch

TM Capital advised NanoGram Devices Corporation in its sale to Greatbatch, Inc. (NYSE: GB) for $45 million in cash

Details

has been acquired by

Portland Professional Acquired by NMHC

TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ)

Details

goodwill impairment valuation analysis

Immucor Goodwill Valuation Analysis

TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142

Details

has been acquired by

Epic Therapeutics Acquired by Baxter International

TM Capital advised Epic Therapeutics in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter

Details
Previous Next
Load More